Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RDGLVIVOS INC

OTC · CIK 0001449349
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts385

Identity from submissions API

NameVIVOS INC
CIK0001449349
TickersRDGL
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3841 Surgical & Medical Instruments & Apparatus
EIN800138937
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone509-736-4000
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ADVANCED MEDICAL ISOTOPE Corp (2008-11-12T00:00:00.000Z → 2017-12-18T00:00:00.000Z)
Business address
719 JADWIN AVENUE
RICHLAND
WA
99352
WA
Mailing address
719 JADWIN AVENUE
RICHLAND
WA
99352
WA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

501 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 xslF345X06/form4-11202026_071123.xml 0002131351-26-000016 4725
2026-11-20 4 xslF345X06/form4-11202026_071106.xml 0001486806-26-000012 5272
2026-11-12 10-Q 10-Q 0001493152-26-051418 000-53497 261547428 34 8382944 1 1
2026-11-09 DEF 14A DEF 14A 0001493152-26-050741 000-53497 261536488 34 2251640 1 1
2026-11-05 8-K 8-K 3.02,5.08,8.01,9.01 0001493152-26-050077 000-53497 261525075 34 359216 1 1
2026-10-08 4 xslF345X06/form4-10082026_091051.xml 0001486807-26-000002 8370
2026-10-08 8-K 8-K 1.01,3.02,3.03,5.03,9.01 0001493152-26-046354 000-53497 261450371 34 277064 1 1
2026-10-05 8-K 8-K 5.03,9.01 0001493152-26-045780 000-53497 261441638 34 333405 1 1
2026-10-01 4 xslF345X06/form4-10012026_091054.xml 0001486806-26-000010 4717
2026-09-16 4 xslF345X06/form4-09162026_030932.xml 0002131351-26-000014 5287
2026-08-12 10-Q 10-Q 0001493152-26-037380 000-53497 261268067 34 5945416 1 1
2026-08-10 4 xslF345X06/form4-08102026_080837.xml 0002131351-26-000012 4730
2026-08-10 4 xslF345X06/form4-08102026_050843.xml 0001486806-26-000008 4732
2026-07-22 4 xslF345X06/form4-07222026_070741.xml 0002131351-26-000010 6196
2026-07-15 4/A xslF345X06/form4a-07152026_040717.xml 0002131351-26-000008 9628
2026-07-15 5 xslF345X06/form5-07152026_040744.xml 0002131351-26-000006 6518
2026-07-15 4 xslF345X06/form4-07152026_030727.xml 0001486806-26-000006 4732
2026-07-10 4 xslF345X06/form4-07102026_050756.xml 0002131351-26-000004 6194
2026-05-14 10-Q 10-Q 0001493152-26-023146 000-53497 26979931 34 5862904 1 1
2026-05-11 4 xslF345X06/form4-05112026_050520.xml 0001486806-26-000004 4731
2026-04-28 3 xslF345X06/form3-04282026_080443.xml 0002131351-26-000002 5246
2026-03-31 10-K 10-K 0001493152-26-013701 000-53497 26815962 34 6728735 1 1
2026-03-05 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-26-000052 024-12713 26728358 33 1817
2026-03-04 CORRESP filename1.htm 0001493152-26-008885 10936
2026-03-04 1-A/A xsl1-A_X01/primary_doc.xml 0001493152-26-008813 024-12713 26719715 33 2641594
2026-02-24 UPLOAD filename1.pdf 0000000000-26-001868 024-12713 40896
2026-02-17 1-A xsl1-A_X01/primary_doc.xml 0001493152-26-006865 024-12713 26635787 33 2565635
2026-01-02 4 xslF345X05/form4-01022026_040118.xml 0001486806-26-000002 4594
2025-12-09 4 xslF345X05/form4-12092025_091200.xml 0001486806-25-000006 4595
2025-11-20 4 xslF345X05/form4-11212025_121139.xml 0001486806-25-000004 4595
2025-11-12 10-Q 10-Q 0001493152-25-021619 000-53497 251468288 34 5827859 1 1
2025-09-24 8-K/A 8-K/A 1.01,5.02,9.01 0001493152-25-014694 000-53497 251334918 34 215596 1 1
2025-09-22 8-K 8-K 1.01,5.02,9.01 0001493152-25-014345 000-53497 251327953 34 22058542 1 1
2025-09-18 8-K 8-K 8.01 0001493152-25-014047 000-53497 251323417 34 191554 1 1
2025-08-14 4 xslF345X05/form4-08142025_060837.xml 0001415889-25-021810 4595
2025-08-13 10-Q 10-Q 0001641172-25-023437 000-53497 251211090 34 5882291 1 1
2025-05-09 10-Q form10-q.htm 0001641172-25-009496 000-53497 25931605 34 4599497 1 1
2025-03-24 10-K form10-k.htm 0001641172-25-000238 000-53497 25763375 34 6553854 1 1
2025-02-10 8-K form8-k.htm 8.01,9.01 0001493152-25-005623 000-53497 25605511 34 240786 1 1
2025-02-10 8-K form8-k.htm 3.02,8.01 0001493152-25-005588 000-53497 25604741 34 208706 1 1
2024-11-18 253G2 form253g2.htm 0001493152-24-046489 024-12456 241471176 33 21665
2024-11-13 10-Q form10-q.htm 0001493152-24-045032 000-53497 241452864 34 5880381 1 1
2024-10-28 4 xslF345X05/form4-10282024_081045.xml 0001415889-24-025674 4601
2024-09-30 4 xslF345X05/form4-09302024_040909.xml 0001415889-24-024085 4601
2024-08-13 4 xslF345X05/form4-08132024_050824.xml 0001415889-24-021126 4601
2024-08-13 10-Q form10-q.htm 0001493152-24-031540 000-53497 241200417 34 4857078 1 1
2024-08-07 4 xslF345X05/form4-08072024_050829.xml 0001415889-24-020862 4601
2024-08-02 4 xslF345X05/form4-08022024_120859.xml 0001415889-24-020572 4601
2024-07-29 4 xslF345X05/form4-07292024_050707.xml 0001415889-24-020244 4601
2024-07-16 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-24-000110 024-12456 241120873 33 1825
2024-07-15 CORRESP filename1.htm 0001493152-24-027196 11492
2024-07-15 1-A/A xsl1-A_X01/primary_doc.xml 0001493152-24-027192 024-12456 241115774 33 1729706
2024-07-12 UPLOAD filename1.pdf 0000000000-24-007952 024-12456 40955
2024-07-01 8-K form8-k.htm 8.01,9.01 0001493152-24-025735 000-53497 241088505 34 226515 1 1
2024-06-28 1-A xsl1-A_X01/primary_doc.xml 0001493152-24-025606 024-12456 241085652 33 1619426
2024-06-04 4 xslF345X05/form4-06042024_060646.xml 0001415889-24-015308 4601
2024-05-09 10-Q form10-q.htm 0001493152-24-018525 000-53497 24932085 34 4868692 1 1
2024-03-25 8-K form8-k.htm 1.01,5.02,9.01 0001493152-24-011040 000-53497 24776690 34 389943 1 1
2024-03-18 10-K form10-k.htm 0001493152-24-010256 000-53497 24758364 34 6218025 1 1
2023-12-27 8-K form8-k.htm 3.02,8.01,9.01 0001493152-23-046266 000-53497 231518408 34 391226 1 1
2023-12-22 253G2 form253g2.htm 0001493152-23-045782 024-11627 231506729 33 17622
2023-12-06 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-23-000378 024-11627 231470982 33 1757
2023-12-05 CORRESP filename1.htm 0001493152-23-043686 11239
2023-11-27 CORRESP filename1.htm 0001493152-23-042810 31787
2023-11-27 1-A POS xsl1-A_X01/primary_doc.xml 0001493152-23-042809 024-11627 231441172 33 2222107
2023-11-14 4 xslF345X05/form4-11142023_041131.xml 0001415889-23-015057 4497
2023-11-08 UPLOAD filename1.pdf 0000000000-23-012250 44746
2023-11-06 10-Q form10-q.htm 0001493152-23-039464 000-53497 231379019 34 5186202 1 1
2023-11-03 CORRESP filename1.htm 0001493152-23-039359 46825
2023-11-03 1-A POS xsl1-A_X01/primary_doc.xml 0001493152-23-039356 024-11627 231377210 33 2117137
2023-10-24 UPLOAD filename1.pdf 0000000000-23-011654 45446
2023-10-19 4 xslF345X05/form4-10192023_041029.xml 0001415889-23-014424 5055
2023-10-11 8-K form8-k.htm 8.01,9.01 0001493152-23-036853 000-53497 231319386 34 263071 1 1
2023-10-10 1-A POS xsl1-A_X01/primary_doc.xml 0001493152-23-036687 024-11627 231316856 33 2118666
2023-08-04 10-Q form10-q.htm 0001493152-23-026796 000-53497 231143719 34 4525471 1 1
2023-05-04 10-Q form10-q.htm 0001493152-23-015400 000-53497 23887469 34 4995558 1 1
2023-05-02 8-K form8-k.htm 3.02,8.01 0001493152-23-015144 000-53497 23877256 34 206706 1 1
2023-03-27 4 xslF345X04/form4-03272023_070322.xml 0001415889-23-005431 4510
2023-03-01 10-K form10-k.htm 0001493152-23-006366 000-53497 23691924 34 6011176 1 1
2022-12-15 4 xslF345X03/form4-12162022_121202.xml 0001415889-22-012603 5023
2022-11-18 4 xslF345X03/form4-11182022_121128.xml 0001415889-22-011531 5023
2022-10-19 10-Q form10-q.htm 0001493152-22-028874 000-53497 221318669 34 5971089 1 1
2022-10-17 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-22-000396 024-11627 221314817 33 1757
2022-10-13 CORRESP filename1.htm 0001493152-22-028369 10440
2022-10-11 UPLOAD filename1.pdf 0000000000-22-011165 40679
2022-10-03 1-A POS xsl1-A_X01/primary_doc.xml 0001493152-22-027447 024-11627 221288139 33 2911623
2022-08-12 4 xslF345X03/form4-08122022_010810.xml 0001415889-22-008537 5016
2022-07-25 10-Q form10-q.htm 0001493152-22-020190 000-53497 221100835 34 6004050 1 1
2022-07-11 8-K form8-k.htm 3.02,8.01,9.01 0001493152-22-018978 000-53497 221075967 34 448675 1 1
2022-07-06 253G2 form253g2.htm 0001493152-22-018607 024-11627 221067111 33 15843
2022-05-10 10-Q form10-q.htm 0001493152-22-012660 000-53497 22908844 34 5375599 1 1
2022-03-29 4 xslF345X03/form4-03292022_080303.xml 0001415889-22-003417 6166
2022-03-18 4 xslF345X03/form4-03182022_030355.xml 0001415889-22-003199 6807
2022-03-07 10-K form10-k.htm 0001493152-22-006171 000-53497 22717820 34 7518084 1 1
2022-01-27 8-K form8-k.htm 8.01,9.01 0001493152-22-002410 000-53497 22563684 34 258037 1 1
2021-12-08 4 xslF345X03/form4-12082021_041234.xml 0001415889-21-005797 4467
2021-10-25 10-Q form10-q.htm 0001493152-21-026256 000-53497 211344820 34 7141858 1 1
2021-10-04 4 xslF345X03/form4-10042021_031024.xml 0001415889-21-004721 8523
2021-09-15 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-21-000291 024-11627 211256870 33 1753
2021-09-13 CORRESP filename1.htm 0001493152-21-022509 10875
2021-09-03 UPLOAD filename1.pdf 0000000000-21-010803 41056
2021-09-01 1-A xsl1-A_X01/primary_doc.xml 0001493152-21-021769 024-11627 211229701 33 2364386
2021-08-10 4 xslF345X03/form4-08102021_020856.xml 0001415889-21-003838 6136
2021-08-02 10-Q form10-q.htm 0001493152-21-018309 000-53497 211136528 34 6929969 1 1
2021-06-08 4 xslF345X03/form4-06082021_040638.xml 0001415889-21-002889 10564
2021-05-11 4 xslF345X03/ownership.xml 0001493152-21-010934 5303
2021-05-10 10-Q form10-q.htm 0001493152-21-010868 000-53497 21906396 34 4601016 1
2021-05-07 8-K form8-k.htm 1.01,5.02,9.01 0001493152-21-010775 000-53497 21903383 34 195326
2021-05-07 4 xslF345X03/ownership.xml 0001493152-21-010737 8255
2021-03-24 10-K form10-k.htm 0001493152-21-006723 000-53497 21768723 34 6092583 1
2021-03-02 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-21-000064 024-11049 21707046 33 1756
2021-03-02 CORRESP filename1.htm 0001493152-21-005165 15544
2021-03-01 1-A POS xsl1-A_X01/primary_doc.xml 0001493152-21-005044 024-11049 21694401 33 3923345
2021-02-25 UPLOAD filename1.pdf 0000000000-21-002278 40651
2021-02-17 1-A POS xsl1-A_X01/primary_doc.xml 0001493152-21-004152 024-11049 21645557 33 3964610
2020-12-23 S-8 forms-8.htm 0001493152-20-024246 333-251665 201413409 33 100645
2020-12-17 4 xslF345X03/ownership.xml 0001493152-20-023817 6618
2020-12-10 8-K form8-k.htm 2.03,3.02,8.01,9.01 0001493152-20-023238 000-53497 201379871 34 210665
2020-12-02 4 xslF345X03/form4-12022020_021215.xml 0001415889-20-002765 5036
2020-11-12 4 xslF345X03/ownership.xml 0001493152-20-021132 4431
2020-11-02 10-Q form10-q.htm 0001493152-20-020309 000-53497 201280321 34 6189588 1
2020-08-13 10-Q/A form10qa.htm 0001493152-20-015501 000-53497 201098936 34 55850
2020-08-06 10-Q form10-q.htm 0001493152-20-014762 000-53497 201078821 34 6250793 1
2020-06-29 10-Q form10-q.htm 0001493152-20-012175 000-53497 20999082 34 6219772 1
2020-06-12 4 xslF345X03/ownership.xml 0001493152-20-011051 4431
2020-06-03 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-20-000096 024-11049 20941829 33 1756
2020-06-02 1-A POS xsl1-A_X01/primary_doc.xml 0001493152-20-010344 024-11049 20935496 33 2287931
2020-06-01 CORRESP filename1.htm 0001493152-20-010346 9356
2020-06-01 CORRESP filename1.htm 0001493152-20-010345 29664
2020-06-01 UPLOAD filename1.pdf 0000000000-20-004840 44321
2020-05-21 1-A POS xsl1-A_X01/primary_doc.xml 0001493152-20-009586 024-11049 20899822 33 2287269
2020-05-20 CORRESP filename1.htm 0001493152-20-009587 29199
2020-05-20 10-K/A form10-ka.htm 0001493152-20-009545 000-53497 20898761 34 57361
2020-05-20 8-K/A form-8ka.htm 8.01 0001493152-20-009454 000-53497 20895604 34 33666
2020-05-20 8-K/A form-8ka.htm 8.01 0001493152-20-009452 000-53497 20895584 34 33626
2020-05-19 UPLOAD filename1.pdf 0000000000-20-004444 47218
2020-05-18 4 xslF345X03/ownership.xml 0001493152-20-009276 4429
2020-05-08 8-K form8-k.htm 8.01 0001493152-20-008061 000-53497 20860383 34 30000
2020-04-30 1-A POS xsl1-A_X01/primary_doc.xml 0001493152-20-007407 024-11049 20834127 33 2287017
2020-04-28 10-K form10-k.htm 0001493152-20-007270 000-53497 20825461 34 7507379 1
2020-04-20 4 xslF345X03/ownership.xml 0001493152-20-006710 4428
2020-03-16 8-K form8-k.htm 8.01 0001493152-20-004097 000-53497 20718383 34 28187
2020-02-27 4 xslF345X03/form4-02272020_120211.xml 0001415889-20-000541 9061
2020-01-17 4/A xslF345X03/form4a-01172020_040128.xml 0001415889-20-000140 11209
2020-01-15 4 xslF345X03/form4-01152020_080132.xml 0001415889-20-000104 10759
2019-11-26 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-19-000199 024-11049 191253106 33 1753
2019-11-22 CORRESP filename1.htm 0001654954-19-013344 8640
2019-11-20 1-A/A xsl1-A_X01/primary_doc.xml 0001493152-19-018130 024-11049 191234809 33 2544528
2019-11-14 10-Q/A form10-qa.htm 0001493152-19-017391 000-53497 191219422 34 1280229
2019-11-12 10-Q form10-q.htm 0001493152-19-016855 000-53497 191207148 34 5788539 1
2019-10-31 CORRESP filename1.htm 0001415889-19-001237 15120
2019-10-29 UPLOAD filename1.pdf 0000000000-19-014952 51131
2019-10-08 1-A/A xsl1-A_X01/primary_doc.xml 0001493152-19-015257 024-11049 191143336 33 3605269
2019-10-08 CORRESP filename1.htm 0001493152-19-015256 16940
2019-10-02 4 xslF345X03/form4-10022019_061055.xml 0001415889-19-001134 16021
2019-09-26 UPLOAD filename1.pdf 0000000000-19-014026 49469
2019-09-09 CORRESP filename1.htm 0001493152-19-013855 42662
2019-09-09 1-A/A xsl1-A_X01/primary_doc.xml 0001493152-19-013853 024-11049 191082355 33 3515353
2019-08-23 UPLOAD filename1.pdf 0000000000-19-012835 50263
2019-08-13 10-Q form10-q.htm 0001493152-19-012191 000-53497 191020388 34 4998934 1
2019-07-29 1-A xsl1-A_X01/primary_doc.xml 0001493152-19-011262 024-11049 19980032 33 3806744
2019-07-02 8-K form8-k.htm 3.03,5.03,8.01,9.01 0001493152-19-010114 000-53497 19936371 34 97144
2019-06-24 10-Q/A form10-qa.htm 0001493152-19-009607 000-53497 19914728 34 4501820 1
2019-05-22 DEFR14C DEFR14C 0001654954-19-006476 000-53497 19846650 34 255268
2019-05-16 DEF 14C DEF 14C 0001654954-19-006189 000-53497 19831677 34 255672
2019-05-13 10-Q form10-q.htm 0001493152-19-006916 000-53497 19818563 34 4473349 1
2019-05-06 4 xslF345X03/form4-05062019_030556.xml 0001415889-19-000510 9588
2019-04-30 4 xslF345X03/form4-04302019_050432.xml 0001415889-19-000490 9073
2019-04-29 PRE 14C PRE 14C 0001654954-19-004913 000-53497 19773195 34 255906
2019-04-02 8-K form8k-04022019_020442.htm 5.03,9.01 0001415889-19-000420 000-53497 19726040 34 115971
2019-03-25 10-K form10-k.htm 0001493152-19-003838 000-53497 19702082 34 5689689 1
2019-01-31 8-K form8k-01312019_020122.htm 1.01,3.02,9.01 0001415889-19-000109 000-53497 19556771 34 16306
2018-12-12 3 xslF345X02/form3-12122018_111249.xml 0001415889-18-001754 9647
2018-12-11 8-K form8k-12102018_041257.htm 5.02 0001415889-18-001740 000-53497 181227549 34 24978
2018-12-06 8-K form8k-12062018_061201.htm 5.02 0001415889-18-001725 000-53497 181218603 34 13701
2018-11-14 10-Q form10-q.htm 0001493152-18-015945 000-53497 181182087 34 2758627 1
2018-11-13 4 xslF345X03/form4-11132018_061102.xml 0001415889-18-001611 13277
2018-11-09 4 xslF345X03/form4-11092018_111149.xml 0001415889-18-001602 9120
2018-10-30 8-K form8-k.htm 1.01,3.02,5.02,9.01 0001493152-18-015013 000-53497 181148005 34 136120
2018-10-26 D xslFormDX01/primary_doc.xml 06b 0001415889-18-001551 021-324434 181140177 33 7282
2018-10-17 8-K CURRENT REPORT 1.01,3.02,5.03,8.01,9.01 0001654954-18-011250 000-53497 181125312 34 629175
2018-10-16 UPLOAD filename1.pdf 0000000000-18-032472 129744
2018-10-05 RW REQUEST FOR WITHDRAWAL 0001654954-18-010866 333-216588 181111106 NE 16656
2018-09-25 8-K form8-k.htm 1.01,9.01 0001493152-18-013697 000-53497 181084612 34 41930
2018-09-21 8-K form8-k.htm 1.01 0001493152-18-013592 000-53497 181082067 34 25957
2018-09-17 SC 13D/A Sc13dakwanyee.txt 0001745338-18-000002 005-88318 181073754 34 15305
2018-08-20 10-Q form10-q.htm 0001493152-18-012269 000-53497 181027005 34 2767034 1
2018-08-14 NT 10-Q formnt-10q.htm 0001493152-18-011851 000-53497 181018379 34 31897
2018-07-18 SC 13G SCHEDULE 13G 0001746805-18-000002 005-88318 18957364 34 5858
2018-07-05 SC 13D INITIAL 13D FILING - KWAN YEE 0001745338-18-000001 005-88318 18940401 34 17309
2018-05-22 10-Q QUARTERLY REPORT 0001654954-18-005743 000-53497 18851783 34 2104037 1
2018-05-15 NT 10-Q form12b25-05152018_110556.htm 0001415889-18-000733 000-53497 18835455 34 19371
2018-04-02 10-K form10-k.htm 0001493152-18-004456 000-53497 18728774 34 19876940 1
2018-03-09 UPLOAD filename1.pdf 0000000000-18-007502 190308
2018-02-16 5 xslF345X03/form5-02162018_120218.xml 0001415889-18-000258 105966
2018-02-13 5 xslF345X03/form5-02132018_040216.xml 0001415889-18-000231 8698
2018-02-13 5 xslF345X03/form5-02132018_040228.xml 0001415889-18-000230 13272
2018-02-09 S-1/A forms-1a.htm 0001493152-18-001692 333-216588 18587321 33 9875474 1
2018-02-08 CORRESP filename1.htm 0001415889-18-000198 69219
2018-01-25 10-K/A form10-ka.htm 0001493152-18-000989 000-53497 18546517 34 6728640 1
2018-01-24 CORRESP filename1.htm 0001415889-18-000122 124828
2018-01-10 UPLOAD filename1.pdf 0000000000-18-001013 134944
2018-01-10 S-8 forms-8.htm 0001493152-18-000398 333-222494 18520987 33 102613
2018-01-09 8-K form8k-01092018_120107.htm 5.02 0001415889-18-000024 000-53497 18519035 34 13679
2018-01-02 8-K form8k-01022018_010106.htm 5.03,8.01 0001415889-18-000004 000-53497 18502222 34 54402
2017-12-18 8-K form8k-12182017_021222.htm 1.01,3.02,9.01 0001415889-17-001952 000-53497 171262272 34 25115
2017-11-21 4 xslF345X03/form4-11212017_101120.xml 0001415889-17-001826 9025
2017-11-13 10-Q form10-q.htm 0001493152-17-012763 000-53497 171192826 34 2988246 1
2017-09-15 8-K form8-k.htm 1.01,5.02 0001493152-17-010629 000-53497 171086547 34 111854
2017-08-11 10-Q form10-q.htm 0001493152-17-008943 000-53497 171024255 34 4074367 1
2017-08-04 8-K form8-k.htm 5.02,5.07 0001493152-17-008551 000-53497 171009421 34 52080
2017-08-01 8-K form8-k.htm 7.01,9.01 0001493152-17-008360 000-53497 17997396 34 1913062 1 1
2017-07-10 DEF 14A def14a.htm 0001493152-17-007645 000-53497 17958432 34 669331
2017-06-28 PRE 14A pre14a.htm 0001493152-17-007233 000-53497 17933592 34 612055
2017-05-17 4 xslF345X03/form4-05172017_060526.xml 0001415889-17-000793 9023
2017-05-15 10-Q form10-q.htm 0001493152-17-005374 000-53497 17845940 34 3716895 1
2017-04-06 UPLOAD filename1.pdf 0000000000-17-011844 190374
2017-03-10 S-1 FORM S-1 0001654954-17-001832 333-216588 17680073 33 5652615 1
2017-03-09 10-K FORM 10-K 0001654954-17-001788 000-53497 17676638 34 5317140 1
2017-01-18 4 xslF345X03/form4-01182017_110109.xml 0001415889-17-000103 10479
2017-01-09 3 xslF345X02/form3.xml 0001493152-17-000267 8203
2016-12-20 8-K form8k-12202016_091201.htm 5.02,9.01 0001415889-16-007602 000-53497 162060391 34 33476
2016-11-21 10-Q form10-q.htm 0001493152-16-015321 000-53497 162010271 34 3956649 1
2016-11-15 NT 10-Q nt10-q.htm 0001493152-16-015074 000-53497 161999166 34 26851
2016-10-17 8-K form8-k.htm 5.03,9.01 0001493152-16-014063 000-53497 161937941 34 42516
2016-09-02 8-K form8-k.htm 4.01 0001493152-16-013053 000-53497 161866721 34 19994
2016-08-25 8-K form8-k.htm 4.01,9.01 0001493152-16-012852 000-53497 161850140 34 96002
2016-08-18 10-Q form10-q.htm 0001493152-16-012654 000-53497 161840789 34 3697773 1
2016-08-15 NT 10-Q nt10-q.htm 0001493152-16-012475 000-53497 161833569 34 26921
2016-06-30 SC 13G SCHEDULE 13G 0001078782-16-003056 005-88318 161743066 34 49524
2016-06-23 4 xslF345X03/form4.xml 0001493152-16-011048 5377
2016-06-10 10-Q form10-q.htm 0001493152-16-010714 000-53497 161708451 34 3478675 1
2016-05-26 10-K/A form10-ka.htm 0001493152-16-010305 000-53497 161676337 34 10747046 1
2016-05-25 10-K form10-k.htm 0001493152-16-010291 000-53497 161675595 34 10745559 1
2016-05-17 NT 10-Q nt10-q.htm 0001493152-16-010039 000-53497 161658420 34 26748
2016-05-10 4 xslF345X03/form4.xml 0001493152-16-009589 6880
2016-05-03 4/A xslF345X03/form4a.xml 0001493152-16-009359 5565
2016-04-18 4 xslF345X03/form4.xml 0001493152-16-009034 5243
2016-04-12 4 xslF345X03/form4.xml 0001493152-16-008813 6881
2016-04-07 4 xslF345X03/form4.xml 0001493152-16-008725 6564
2016-04-07 8-K form8-k.htm 5.03,5.07,9.01 0001493152-16-008703 000-53497 161558578 34 160749
2016-03-30 NT 10-K ADVANCED MEDICAL ISOTOPE CORP. 12/31/2015 NT 10-K 0001199835-16-000701 000-53497 161540417 34 43737
2016-02-16 5 FORM 5 0001140361-16-052638 12941
2016-02-12 5 FORM 5 0001140361-16-052425 8674
2016-02-12 5 FORM 5 0001140361-16-052240 19169
2016-02-12 5 FORM 5 0001140361-16-052153 4476
2016-02-12 4 FORM 4 0001140361-16-052099 5604
2016-01-21 4 FORM 4 0001140361-16-048345 5122
2016-01-19 8-K ADVANCED MEDICAL ISOTOPE CORPORATION FORM 8-K 4.01,9.01 0001199835-16-000600 000-53497 161347854 34 35295
2016-01-15 SC 13G/A NONE 0001140361-16-047890 005-88318 161345064 34 112524
2015-12-14 DEF 14C admddef14c_nov2015.htm 0001415889-15-004045 000-53497 151286382 34 540913
2015-12-10 4 xslF345X03/form4-12102015_061239.xml 0001415889-15-004027 5556
2015-12-10 4 xslF345X03/form4-12102015_061254.xml 0001415889-15-004025 5432
2015-11-25 10-Q/A FORM 10-Q 0001415889-15-003878 000-53497 151254444 34 4383108 1
2015-11-24 10-Q FORM 10-Q 0001415889-15-003859 000-53497 151251458 34 1150628
2015-11-16 NT 10-Q form12b25-11162015_041106.htm 0001415889-15-003741 000-53497 151234330 34 20625
2015-10-30 PRE 14C admdpre14c_oct2015.htm 0001415889-15-003552 000-53497 151188646 34 541355
2015-10-08 4 xslF345X03/form4-10082015_021004.xml 0001415889-15-003330 8288
2015-09-16 8-K form8k-09152015_050937.htm 1.01,3.02,9.01 0001415889-15-003085 000-53497 151108755 34 136350
2015-09-14 4 xslF345X03/form4-09142015_050959.xml 0001415889-15-003067 9936
2015-09-11 4 xslF345X03/form4-09112015_060903.xml 0001415889-15-003032 8735
2015-09-08 4 xslF345X03/form4-09082015_090904.xml 0001415889-15-003001 5478
2015-08-25 4 xslF345X03/form4-08252015_100801.xml 0001415889-15-002882 9804
2015-08-19 10-Q 10-Q 0001415889-15-002806 000-53497 151064776 34 4046671 1
2015-08-17 4 xslF345X03/form4-08172015_020856.xml 0001415889-15-002786 10516
2015-08-14 NT 10-Q form12b25-08132015_040814.htm 0001415889-15-002693 000-53497 151052161 34 19800
2015-07-08 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 5.03,9.01 0001199835-15-000279 000-53497 15977518 34 156369
2015-07-07 4 FORM 4 0001140361-15-026990 9853
2015-07-07 4 FORM 4 0001140361-15-026988 9723
2015-07-01 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 8.01,9.01 0001199835-15-000275 000-53497 15965241 34 62220
2015-05-27 10-Q/A ADVANCED MEDICAL ISOTOPE CORP. 03/31/2015 10-Q/A, AMENDMENT NO. 1 0001199835-15-000231 000-53497 15892747 34 3776276 1
2015-05-15 10-Q ADVANCED MEDICAL ISOTOPE CORP. 03/31/2015 10-Q 0001199835-15-000192 000-53497 15867300 34 992817
2015-05-04 8-K/A ADVANCED MEDICAL ISOTOPE CORP. 8-K/A, AMENDMENT NO. 1 2.04,9.01 0001199835-15-000169 000-53497 15825845 34 205201
2015-05-01 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 2.04,9.01 0001199835-15-000167 000-53497 15824038 34 106739
2015-04-30 4 FORM 4 0001140361-15-017113 10376
2015-04-21 10-K/A ADVANCED MEDICAL ISOTOPE CORP. 12/31/2014 10-K/A, AMENDMENT NO. 1 0001199835-15-000146 000-53497 15782641 34 6338469 1
2015-04-20 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 5.02 0001199835-15-000140 000-53497 15779358 34 28043
2015-04-15 10-K ADVANCED MEDICAL ISOTOPE CORP. 12/31/2014 10-K 0001199835-15-000132 000-53497 15772602 34 2798068
2015-04-09 4/A FORM 4/A 0001140361-15-014976 4607
2015-04-09 4/A FORM 4/A 0001140361-15-014973 10652
2015-04-09 4/A FORM 4/A 0001140361-15-014969 10691
2015-04-09 4/A FORM 4/A 0001140361-15-014965 10654
2015-03-31 NT 10-K ADVANCED MEDICAL ISOTOPE CORP. NT 10-K 0001199835-15-000081 000-53497 15737595 34 62775
2015-02-26 4 FORM 4 0001140361-15-009077 4295
2015-02-26 4 FORM 4 0001140361-15-009067 10380
2015-02-23 5 FORM 5 0001140361-15-008448 4425
2015-02-23 5 FORM 5 0001140361-15-008446 12613
2015-02-23 5 FORM 5 0001140361-15-008443 7813
2015-02-23 5 FORM 5 0001140361-15-008441 5772
2015-02-23 5 FORM 5 0001140361-15-008437 41275
2015-02-23 5 FORM 5 0001140361-15-008434 43943
2015-02-23 4 FORM 4 0001140361-15-008367 10379
2015-01-16 4 FORM 4 0001140361-15-002027 10381
2015-01-16 SC 13G/A NONE 0001140361-15-001982 005-88318 15531484 34 116056
2014-12-22 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 2.03 0001199835-14-000639 000-53497 141302126 34 23676
2014-12-19 4 FORM 4 0001140361-14-045884 10384
2014-12-19 4 FORM 4 0001140361-14-045882 6759
2014-11-25 4 FORM 4 0001140361-14-043408 10370
2014-11-14 4 FORM 4 0001140361-14-042289 10372
2014-11-14 10-Q ADVANCED MEDICAL ISOTOPE CORPORATION 10K 9-30-2014 0001199835-14-000558 000-53497 141220079 34 3951263 1
2014-10-30 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 5.07,9.01 0001199835-14-000525 000-53497 141183623 34 156463
2014-10-15 4 FORM 4 0001140361-14-038157 10372
2014-10-02 DEF 14A ADVANCED MEDICAL ISOTOPE CORP. DEF 14A 0001199835-14-000492 000-53497 141134283 34 706886
2014-09-25 PRE 14A ADVANCED MEDICAL ISOTOPE CORP. PRE 14A 0001199835-14-000479 000-53497 141120832 34 699602
2014-09-19 SC 13G NONE 0001140361-14-036036 005-88318 141111233 34 116177
2014-09-17 4 FORM 4 0001140361-14-035831 10373
2014-08-18 4 FORM 4 0001140361-14-033287 10363
2014-08-14 10-Q ADVANCED MEDICAL 10Q 06-30-2014 #16099 0001199835-14-000403 000-53497 141042314 34 4009072 1
2014-07-17 4 FORM 4 0001140361-14-028618 10361
2014-07-09 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 3.02,9.01 0001199835-14-000352 000-53497 14967203 34 40496
2014-06-17 3 PRIMARY DOCUMENT 0001117174-14-000003 4616
2014-06-17 4 FORM 4 0001140361-14-025876 10363
2014-06-12 4 FORM 4 0001140361-14-025403 4282
2014-06-06 8-K advancedmed_8k.htm 5.07,9.01 0001199835-14-000295 000-53497 14897281 34 44773
2014-05-19 4 FORM 4 0001140361-14-022084 10353
2014-05-15 DEF 14A ADVANCED MEDICAL ISOTOPE CORP. DEF 14A 0001199835-14-000230 000-53497 14848769 34 522065
2014-05-15 10-Q ADVANCED MEDICAL ISOTOPE CORPORATION 10Q 03 31 2014 #15994 0001199835-14-000218 000-53497 14846393 34 3991126 1
2014-05-07 PRE 14A ADVANCED MEDICAL ISOTOPE CORPORATION PRE14A 15989 0001199835-14-000192 000-53497 14822127 34 262890
2014-04-17 4 FORM 4 0001140361-14-017057 10356
2014-03-31 10-K ADVANCED MEDICAL ISOTOPE CORPORATION 10K 12-31-2013 0001199835-14-000135 000-53497 14730707 34 8745366 1
2014-02-05 5 FORM 5 0001140361-14-004823 27846
2014-02-05 5 FORM 5 0001140361-14-004821 43889
2014-02-04 5 FORM 5 0001140361-14-004587 4409
2014-02-04 5 FORM 5 0001140361-14-004584 13929
2014-02-04 5 FORM 5 0001140361-14-004582 9129
2014-02-04 5 FORM 5 0001140361-14-004580 5756
2014-01-17 4 FORM 4 0001140361-14-002507 10358
2014-01-16 8-K AMIC 8K 01-15-2014 2.02,9.01 0001199835-14-000023 000-53497 14530691 34 39541
2013-12-17 4 FORM 4 0001140361-13-046508 10361
2013-11-19 10-Q/A ADVANCED MEDICAL ISOTOPE CORP. 09/30/2013 10-Q/A, AMENDMENT NO. 1 0001199835-13-000786 000-53497 131229890 34 4351349 1
2013-11-15 4 FORM 4 0001140361-13-043122 10360
2013-11-15 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 8.01 0001199835-13-000759 000-53497 131222163 34 48940
2013-11-14 10-Q ADVANCED MEDICAL ISOTOPE CORP. 09/30/2013 10-Q 0001199835-13-000751 000-53497 131220448 34 1274797
2013-11-01 3 FORM 3 0001140361-13-040264 6278
2013-10-18 8-K ADVANCED MEDICAL ISOTOPE CORPORATION 8K 5.02,9.01 0001199835-13-000682 000-53497 131157851 34 188304
2013-10-16 4 FORM 4 0001140361-13-038800 10360
2013-10-16 8-K ADVANCED MEDICAL ISOTOPE CORPORATION FORM 8K 7.01,9.01 0001199835-13-000662 000-53497 131152888 34 2370259
2013-09-13 4 FORM 4 0001140361-13-035956 10365
2013-09-09 4 FORM 4 0001140361-13-035388 4291
2013-09-05 4/A FORM 4/A 0001140361-13-035061 10439
2013-09-04 4/A FORM 4/A 0001140361-13-035014 10437
2013-08-16 4 FORM 4 0001140361-13-033408 4291
2013-08-16 4 FORM 4 0001140361-13-033406 10361
2013-08-14 10-Q ADVANCED MEDICAL ISOTOPE CORP. 06/30/2013 10-Q 0001199835-13-000503 000-53497 131038200 34 5761157 1
2013-08-13 4 FORM 4 0001140361-13-031951 4291
2013-08-12 4 FORM 4 0001140361-13-031682 4292
2013-08-01 4 FORM 4 0001140361-13-030024 10359
2013-07-19 4 FORM 4 0001140361-13-028475 5711
2013-07-11 4 FORM 4 0001140361-13-027969 10360
2013-07-02 4 FORM 4 0001140361-13-027147 4290
2013-07-01 4 FORM 4 0001140361-13-026905 4290
2013-06-17 4 FORM 4 0001140361-13-025503 10362
2013-05-21 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 3.02,3.03 0001199835-13-000299 000-53497 13862629 34 27361
2013-05-15 10-Q ADVANCED MEDICAL ISOTOPE CORP. 03/31/2013 10-Q 0001199835-13-000250 000-53497 13843259 34 3452301 1
2013-05-14 4 FORM 4 0001140361-13-020498 4289
2013-05-03 D xslFormDX01/primary_doc.xml 06 0001199835-13-000221 021-195963 13811994 33 9697
2013-04-24 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 1.01,3.02,9.01 0001199835-13-000205 000-53497 13779888 34 487964
2013-03-29 10-K ADVANCED MEDICAL ISOTOPE CORP. 10-K 0001199835-13-000143 000-53497 13728377 34 8758947 1
2013-03-15 D xslFormDX01/primary_doc.xml 06 0001199835-13-000110 021-193419 13694922 33 9699
2013-03-15 4 FORM 4 0001140361-13-012694 4434
2013-03-15 4 FORM 4 0001140361-13-012676 4305
2013-03-07 8-K ADVANCED MEDICAL ISOTOPE CORPORATION FORM 8K 1.01,3.02,9.01 0001199835-13-000102 000-53497 13674158 34 321333
2013-03-01 4 FORM 4 0001140361-13-010157 4305
2013-02-06 5 FORM 5 0001140361-13-005001 11811
2013-02-06 5 FORM 5 0001140361-13-004999 43929
2013-02-06 5 FORM 5 0001140361-13-004970 6484
2013-02-06 5 FORM 5 0001140361-13-004966 4431
2013-02-06 5 FORM 5 0001140361-13-004964 3156
2013-02-06 5 FORM 5 0001140361-13-004958 6354
2013-01-23 4 FORM 4 0001140361-13-002863 10360
2013-01-22 4 FORM 4 0001140361-13-002623 10364
2013-01-15 4 FORM 4 0001140361-13-002191 5960
2012-12-26 4 FORM 4 0001140361-12-052717 10365
2012-12-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2012-12-10 16:00:00 9999999995-12-003483 333-183705 121254802 33 1683
2012-12-07 CORRESP filename1.htm 0001199835-12-000848 10750
2012-11-28 S-1/A ADVANCED MEDICAL ISOTOPE CORP. S-1/A, AMENDMENT NO. 3 0001199835-12-000829 333-183705 121229213 33 3273038
2012-11-13 10-Q ADVANCED MEDICAL ISOTOPE CORP. 10-Q 0001199835-12-000741 000-53497 121196842 34 3647163 1
2012-11-02 4 FORM 4 0001140361-12-045509 10358
2012-11-02 4 FORM 4 0001140361-12-045504 4434
2012-11-01 4 FORM 4 0001140361-12-045169 5724
2012-10-31 UPLOAD filename1.pdf 0000000000-12-059599 207023
2012-10-30 4 FORM 4 0001140361-12-044983 10365
2012-10-17 4 FORM 4 0001140361-12-044063 10365
2012-10-16 S-1/A ADVANCED MEDICAL ISOTOPE CORP. S-1/A, AMENDMENT NO. 2 0001199835-12-000688 333-183705 121146723 33 3128951
2012-10-01 UPLOAD filename1.pdf 0000000000-12-053993 220363
2012-09-14 8-K ADVANCED MEDICAL ISOTOPE CORP. 8-K 5.02,9.01 0001199835-12-000624 000-53497 121092890 34 38133
2012-09-12 3 FORM 3 0001140361-12-040149 3971
2012-09-06 S-1/A ADVANCED MEDICAL ISOTOPE CORP. S-1/A, AMENDMENT NO. 1 0001199835-12-000610 333-183705 121077632 33 2839627
2012-09-04 S-1 ADVANCED MEDICAL ISOTOPE CORP. S-1 0001199835-12-000600 333-183705 121070610 33 2807578
2012-08-31 4 FORM 4 0001140361-12-039047 10363
2012-08-20 8-K ADVANCED MEDICAL ISOTOPE CORPORATION FORM 8K 3.02 0001199835-12-000562 000-53497 121043470 34 22911
2012-08-17 4 FORM 4 0001140361-12-037659 4435
2012-08-14 10-Q ADVANCED MEDICAL ISOTOPE CORP. 06/30/2012 10-Q 0001199835-12-000529 000-53497 121030577 34 3492663 1
2012-08-02 8-K ADVANCED MEDICAL FORM 8K 1.01,2.03,3.02,8.01 0001199835-12-000490 000-53497 121004155 34 806328
2012-07-18 8-K ADVANCED MEDICAL FORM 8K 1.01,2.03,3.02,9.01 0001199835-12-000471 000-53497 12968551 34 1854509
2012-06-08 8-K ADVANCED MEDICAL FORM 8K 06-04-2012 2.03,3.02 0001199835-12-000415 000-53497 12897920 34 27694
2012-06-01 4 FORM 4 0001140361-12-028320 10362
2012-05-29 D xslFormDX01/primary_doc.xml 06 0000893877-12-000065 021-178927 12874498 33 10590
2012-05-21 4 FORM 4 0001140361-12-026584 10362
2012-05-14 10-Q ADVANCED MEDICAL FORM 10Q 03-31-2012 0001199835-12-000314 000-53497 12839156 34 2274988 1

Latest XBRL company facts

One latest value per concept from companyfacts (385 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 494.74M 2026-11-12 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
dei EntityPublicFloat Entity Public Float USD 47.71M 2025-06-30 2025 FY 10-K 2026-03-31 0001493152-26-013701
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 313,625 2025-01-01 2025-12-31 DEF 14A 2026-11-09 0001493152-26-050741
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 337,625 2025-01-01 2025-12-31 DEF 14A 2026-11-09 0001493152-26-050741
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 347,320 2025-01-01 2025-12-31 DEF 14A 2026-11-09 0001493152-26-050741
ecd PeoTotalCompAmt PeoTotalCompAmt USD 347,320 2025-01-01 2025-12-31 DEF 14A 2026-11-09 0001493152-26-050741
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 153 2025-01-01 2025-12-31 DEF 14A 2026-11-09 0001493152-26-050741
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 0.046 2014-05-01 2014-05-15 2015 FY 10-K/A 2016-05-26 0001493152-16-010305
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 125,438 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap AccountsPayableRelatedPartiesCurrentAndNoncurrent Accounts Payable, Related Parties USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 13,000 2022-03-31 2022 Q1 10-Q 2022-05-10 0001493152-22-012660
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 27,825 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 28,846 2017-06-30 2017 Q2 10-Q 2017-08-11 0001493152-17-008943
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 18,892 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -314 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 83.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AdditionalPaidInCapitalPreferredStock Additional Paid in Capital, Preferred Stock USD 9.50M 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap AdjustmentForAmortization Amortization USD 431,154 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 59,957 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006723
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 1,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 80,059 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 9,995 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 412,980 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-14 0001199835-12-000529
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD -131,090 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 10,800 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD 983,793 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AdvertisingExpense Advertising Expense USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q/A 2019-06-24 0001493152-19-009607
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 53,527 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 13,917 2015-01-01 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 13,917 2015-01-01 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 98.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 43,957 2016-01-01 2016-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap Assets Assets USD 2.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AssetsCurrent Assets, Current USD 1.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap AssetsFairValueDisclosureRecurring Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) USD 0 2016-12-31 2016 FY 10-K 2017-03-09 0001654954-17-001788
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 2.81M 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 39,481 2014-12-31 2015 FY 10-K/A 2016-05-26 0001493152-16-010305
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 0 2011-12-31 2011 FY 10-K 2012-03-23 0001199835-12-000130
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 39,481 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap CapitalLeasesFutureMinimumPaymentsDueThereafter Capital Leases, Future Minimum Payments Due Thereafter USD 0 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 0 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1 Capital Leases, Future Minimum Payments, Net Minimum Payments USD 39,481 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 39,481 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap Cash Cash USD 1.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3.27M 2025-03-31 2025 Q1 10-Q 2025-05-09 0001641172-25-009496
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -8,317 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 248,825 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.075 2026-03-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 2.80M 2026-04-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037380
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 11.24M 2021-03-31 2022 Q1 10-Q 2022-05-10 0001493152-22-012660
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 950.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 494.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 494.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 1,500 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap CommonStocksIncludingAdditionalPaidInCapital Common Stocks, Including Additional Paid in Capital USD 130,000 2024-03-31 2024 Q1 10-Q 2024-05-09 0001493152-24-018525
us-gaap CommonStockValue Common Stock, Value, Issued USD 494,738 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap CommonUnitIssued Common Unit, Issued shares 30,644 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -2.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 94,515 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 10.08M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap ConvertibleDebt Convertible Debt USD 300,000 2020-03-31 2020 Q1 10-Q 2020-06-29 0001493152-20-012175
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 935,806 2015-03-31 2015 Q1 10-Q 2015-05-27 0001199835-15-000231
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 395,102 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 740,000 2015-09-30 2015 Q3 10-Q 2015-11-25 0001415889-15-003878
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 107,418 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 107,418 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 89,644 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 474 2015-01-01 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap CostOfServicesDirectMaterials Cost of Services, Direct Materials (Deprecated 2018-01-31) USD 72,820 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 32,110 2021-01-01 2021-12-31 2022 Q2 10-Q 2022-07-25 0001493152-22-020190
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 694,178 2020-04-01 2020-04-30 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 6,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001654954-17-001788
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 5,000 2015-01-01 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap DebtCurrent Debt, Current USD 33,086 2012-09-30 2012 Q3 10-Q 2012-11-13 0001199835-12-000741
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 10,879 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 35,846 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 1.44M 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent Debt Instrument, Convertible, Carrying Amount of Equity Component USD 1.27M 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.001 2015-09-30 2015 Q3 10-Q 2015-11-25 0001415889-15-003878
us-gaap DebtInstrumentConvertibleInterestExpense Debt Instrument, Convertible, Interest Expense (Deprecated 2013-01-31) USD 84,243 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 129,745 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-02 0001493152-21-018309
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 100,000 2019-02-20 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 1.49M 2015-09-30 2015 Q3 10-Q 2015-11-25 0001415889-15-003878
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 185,346 2021-12-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap DebtInstrumentIncreaseDecreaseForPeriodNet Debt Instrument, Increase (Decrease), Net USD 809,835 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.1 2013-01-01 2013-05-01 2015 FY 10-K/A 2016-05-26 0001493152-16-010305
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2019-02-20 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap DebtInstrumentRepurchaseAmount Debt Instrument, Repurchase Amount USD 228,332 2018-04-19 2019 Q2 10-Q 2019-08-13 0001493152-19-012191
us-gaap DebtInstrumentSinkingFundPayment Debt Instrument, Sinking Fund Payment USD 4.60M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001493152-17-012763
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 24,545 2019-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006723
us-gaap DebtInstrumentUnamortizedDiscountPremiumNet Debt Instrument, Unamortized Discount (Premium), Net USD 4,896 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap DebtInstrumentUnusedBorrowingCapacityAmount Debt Instrument, Unused Borrowing Capacity, Amount USD 419,055 2016-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD -5,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-25 0001415889-15-003878
us-gaap DebtorReorganizationItemsGainLossOnAssetSalesNet1 Debtor Reorganization Items, Gain (Loss) on Asset Sales, Net USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net USD 526,222 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 13,917 2014-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 13,917 2014-12-31 2015 FY 10-K/A 2016-05-26 0001493152-16-010305
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 3,400 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2016-12-31 2016 FY 10-K 2017-03-09 0001654954-17-001788
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2016-12-31 2016 FY 10-K 2017-03-09 0001654954-17-001788
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 7.69M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 341,200 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 6,400 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 379,800 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 7.69M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2021-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 114,150 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap Deposits Deposits USD 370,000 2012-06-30 2012 Q2 10-Q 2012-08-14 0001199835-12-000529
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 1,000 2014-09-30 2014 Q3 10-Q 2014-11-14 0001199835-14-000558
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 669 2017-12-31 2018 FY 10-K 2019-03-25 0001493152-19-003838
us-gaap Depreciation Depreciation USD 18,518 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1,473 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-25 0001493152-19-003838
us-gaap DerivativeAssetFairValueGrossLiability Derivative Asset, Fair Value, Gross Liability USD 324,532 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 324,532 2016-12-31 2018 FY 10-K 2019-03-25 0001493152-19-003838
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -186,846 2018-01-01 2018-12-31 2019 FY 10-K 2020-04-28 0001493152-20-007270
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 30.06M 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap DueFromRelatedParties Due from Related Parties USD 127,533 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 15,000 2019-06-30 2019 Q2 10-Q 2019-08-13 0001493152-19-012191
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 497,880 2020-06-30 2020 Q3 10-Q 2020-11-02 0001493152-20-020309
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 127,533 2016-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 332,195 2016-06-30 2016 Q2 10-Q 2016-08-18 0001493152-16-012654
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.01 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.546 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 66,143 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap EntityWideRevenueMajorCustomerPercentage Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) pure 0.727 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.05 2007-07-17 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 5.93M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-25 0001415889-15-003878
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 77,883 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap FeesAndCommissions Fees and Commissions (Deprecated 2018-01-31) USD 25,000 2016-01-01 2016-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD -112,500 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 25,000 2016-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 4,000 2021-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 10,000 2020-09-30 2020 Q3 10-Q 2020-11-02 0001493152-20-020309
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 10,000 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 4,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001493152-19-016855
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 4,000 2020-06-30 2020 Q2 10-Q 2020-08-06 0001493152-20-014762
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 4,000 2022-03-31 2022 Q1 10-Q 2022-05-10 0001493152-22-012660
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 112,500 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 4,000 2022-03-31 2022 Q1 10-Q 2022-05-10 0001493152-22-012660
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -176,295 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001493152-21-010868
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-23 0001199835-12-000130
us-gaap GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome Gain (Loss) on Sale of Previously Unissued Stock by Subsidiary or Equity Investee, Nonoperating Income USD -847,628 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -25,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-23 0001199835-12-000130
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD -43,957 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 47,588 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010256
us-gaap GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost USD 35,217 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-25 0001493152-19-003838
us-gaap GainsLossesOnRecourseDebt Gains (Losses) on Recourse Debt USD 3,574 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-25 0001415889-15-003878
us-gaap GainsLossesOnRestructuringOfDebt Gains (Losses) on Restructuring of Debt USD 1.46M 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap GainsLossesOnSalesOfAssets Gain (Loss) on Disposition of Assets for Financial Service Operations USD 2,800 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-25 0001493152-19-003838
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 344,418 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 35,482 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap GrossProfit Gross Profit USD 11,724 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss Impaired Assets to be Disposed of by Method Other than Sale, Amount of Impairment Loss USD 16,661 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -2.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -2.15M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-02 0001493152-21-018309
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001654954-17-001788
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-22 0001654954-18-005743
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 428,800 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 643,900 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap IncomeTaxReconciliationNondeductibleExpenseDepreciation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 113,100 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount USD 300 2018-01-01 2018-12-31 2019 FY 10-K 2020-04-28 0001493152-20-007270
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 6,300 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000238
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 216,100 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -67,100 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 239,596 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 32,966 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -6,500 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006723
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 5,494 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD 370,000 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-14 0001199835-12-000529
us-gaap IncreaseDecreaseInDepositsOutstanding Increase (Decrease) in Deposits Outstanding USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-23 0001199835-12-000130
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 2.55M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 51,576 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -66,143 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap IncreaseDecreaseInInsuranceSettlementsReceivable Increase (Decrease) in Insurance Settlements Receivable USD 25,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001199835-11-000724
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD -25,399 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -1,260 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 2,011 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD 141,250 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-25 0001415889-15-003878
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 9,196 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 4,351 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 28,793 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-13 0001493152-19-012191
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 2.31B 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 11.49B 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 35,482 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap IndefiniteLivedLicenseAgreements Indefinite-Lived License Agreements USD 4,000 2022-09-30 2022 Q3 10-Q 2022-10-19 0001493152-22-028874
us-gaap InducedConversionOfConvertibleDebtExpense Induced Conversion of Convertible Debt Expense USD 78,198 2012-07-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001199835-12-000741
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 35,482 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap InterestExpense Interest Expense USD 25,375 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap InterestExpenseDebt Interest Expense, Debt USD 1,491 2015-01-01 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap InterestExpenseShortTermBorrowings Interest Expense, Short-term Borrowings USD 2,031 2014-01-01 2014-12-31 2015 FY 10-K/A 2016-05-26 0001493152-16-010305
us-gaap InterestExpenseSubordinatedNotesAndDebentures Interest Expense, Subordinated Notes and Debentures USD 27,685 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001199835-12-000741
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 49,859 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 9,920 2016-01-01 2016-03-31 2017 Q1 10-Q 2017-05-15 0001493152-17-005374
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 50,773 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap InterestPayableCurrent Interest Payable, Current USD 100,954 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 619 2020-04-30 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap InventoryNet Inventory, Net USD 55,997 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap InventoryWriteDown Inventory Write-down USD 8,475 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-23 0001199835-12-000130
us-gaap Investments Investments USD 5,000 2011-02-28 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 86,419 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 465,739 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-25 0001493152-19-003838
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.045 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 33,460 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2,788 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 33,460 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 33,460 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap Liabilities Liabilities USD 221,600 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 2.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LiabilitiesCurrent Liabilities, Current USD 155,179 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 3.94M 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap LiabilitiesFairValueDisclosureRecurring Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) USD 324,532 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 66,421 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 33,086 2012-09-30 2012 Q3 10-Q 2012-11-13 0001199835-12-000741
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 2,760 2012-09-30 2012 Q3 10-Q 2012-11-13 0001199835-12-000741
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0001493152-22-012660
us-gaap MarketingExpense Marketing Expense USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 2.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -193,140 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -1.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -2.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000238
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -2.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -797,769 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap NotesIssued1 Notes Issued USD 28,450 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000238
us-gaap NotesPayable Notes Payable USD 32,279 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap NotesPayableCurrent Notes Payable, Current USD 100,000 2019-12-31 2020 Q3 10-Q 2020-11-02 0001493152-20-020309
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 237,000 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap NotesReduction Notes Reduction USD 205,283 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-11 0001493152-17-008943
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OperatingExpenses Operating Expenses USD 1.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -1.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 26,828 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 96,162 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 29,741 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 66,421 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 90,583 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 36.62M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap OtherAssets Other Assets USD 93,583 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -314 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap OtherIncome Other Income USD 3,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001493152-20-014762
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 3,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 0 2016-01-01 2016-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap PaymentsForOperatingActivities Payments for Operating Activities USD 2.30M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001493152-19-016855
us-gaap PaymentsForOtherDeposits Payments for Other Deposits USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap PaymentsForRent Payments for Rent USD 438,830 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap PaymentsOfCapitalDistribution Payments of Capital Distribution USD 5,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001654954-17-001788
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 5,000 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-21 0001493152-16-015321
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 5,000 2015-01-01 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 101,631 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-25 0001493152-19-003838
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-27 0001199835-15-000231
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-23 0001199835-12-000130
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 193,140 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 2.77M 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 2.77M 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 2,770 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 22,152 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 11,591 2014-09-30 2014 Q3 10-Q 2014-11-14 0001199835-14-000558
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 0 2014-03-31 2014 Q1 10-Q 2014-05-15 0001199835-14-000218
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 50,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 150,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 7.25M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000238
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.55M 2026-03-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023146
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 50,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006723
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 19,200 2020-11-29 2020-12-02 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 650,800 2026-04-01 2026-04-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037380
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 15,000 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-10 0001493152-21-010868
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 40,949 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap ProceedsFromSaleOfOtherAssets Proceeds from Sale of Other Assets (Deprecated 2013-01-31) USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-23 0001199835-12-000130
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 2,800 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-25 0001493152-19-003838
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD -255,000 2015-01-01 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 60,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006723
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1,500 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap ProductionCosts Production Costs, Period Cost USD 2,500 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001493152-23-015400
us-gaap ProfessionalFees Professional Fees USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 15,182 2017-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 277,433 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 1,500 2023-03-31 2023 Q1 10-Q 2023-05-04 0001493152-23-015400
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 20,196 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-14 0001199835-13-000503
us-gaap RelatedPartyTransactionRate Related Party Transaction, Rate pure 0.1 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001493152-17-012763
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 45,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap RepaymentsOfDebt Repayments of Debt USD 228,332 2018-04-18 2018-04-19 2019 Q1 10-Q/A 2019-06-24 0001493152-19-009607
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 11,118 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037380
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 39,481 2015-01-01 2015-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-15 0001199835-14-000218
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 50,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 40,949 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001654954-17-001788
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross USD 44,268 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-21 0001199835-15-000146
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 118,907 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 494,935 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001641172-25-023437
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -91.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 101,368 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 17,583 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-22 0001654954-18-005743
us-gaap Revenues Revenues USD 4,995 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000238
us-gaap RoyaltyExpense Royalty Expense USD 4,601 2017-02-01 2017-02-28 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap SalesRevenueEnergyServices Sales Revenue, Energy Services (Deprecated 2018-01-31) USD 265,531 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 24,108 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-25 0001415889-15-003878
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-22 0001654954-18-005743
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 4,233 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-06-29 0001493152-20-012175
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.61M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001493152-21-010868
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.66 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010256
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.47 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006723
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001493152-21-010868
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.03 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010256
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.006 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006723
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001493152-21-010868
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 709,375 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-25 0001493152-21-026256
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 679.10M 2015-01-01 2015-12-31 2015 FY 10-K/A 2016-05-26 0001493152-16-010305
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 28,648 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.13 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 24.13M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 23.25M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-24 0001493152-21-006723
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 13.34M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 28,648 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.14 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 540,000 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 540,000 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 515,975 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-04 0001493152-23-026796
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 385 2019-01-01 2019-01-31 2020 FY 10-K 2021-03-24 0001493152-21-006723
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.18 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0.21 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001199835-14-000135
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.11 2018-01-01 2018-12-31 2019 FY 10-K 2020-04-28 0001493152-20-007270
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 0.04 2021-06-30 2021 Q2 10-Q 2021-08-02 0001493152-21-018309
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 0.15 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 0.04 2021-06-30 2021 Q2 10-Q 2021-08-02 0001493152-21-018309
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 0.2 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap SharePrice Share Price USD/shares 0.064 2023-12-31 2024 Q1 10-Q 2024-05-09 0001493152-24-018525
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.1 2021-09-15 2021 FY 10-K 2022-03-07 0001493152-22-006171
us-gaap ShortTermBorrowings Short-term Debt USD 195,500 2015-06-30 2015 Q2 10-Q 2015-08-19 0001415889-15-002806
us-gaap ShortTermDebtWeightedAverageInterestRate Short-term Debt, Weighted Average Interest Rate, at Point in Time pure 0.1 2015-06-30 2015 Q2 10-Q 2015-08-19 0001415889-15-002806
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 12,592 2019-04-01 2019-06-30 2019 Q2 10-Q 2019-08-13 0001493152-19-012191
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap StockIssued1 Stock Issued USD 743 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 1.26M 2021-01-01 2021-01-31 2021 Q2 10-Q 2021-08-02 0001493152-21-018309
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 393,333 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 523,750 2026-09-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 2.80M 2026-04-01 2026-04-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037380
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 100,000 2025-04-01 2025-04-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037380
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture shares 313,120 2012-07-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001199835-12-000741
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 2.50M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 226,665 2021-01-01 2021-03-31 2022 Q3 10-Q 2022-10-19 0001493152-22-028874
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 109,813 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-25 0001415889-15-003878
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 412,011 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0001493152-23-006366
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 410,581 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-29 0001199835-13-000143
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 28,038 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 640,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 28,450 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000238
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD -52,094 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-22 0001654954-18-005743
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 410,945 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-14 0001199835-12-000529
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 250 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001493152-18-004456
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 45,400 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-015945
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 14.14M 2016-12-31 2016 FY 10-K/A 2018-01-25 0001493152-18-000989
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 186,846 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-25 0001493152-19-003838
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-013701
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 20,000 2022-07-31 2024 Q1 10-Q 2024-05-09 0001493152-24-018525
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 482.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 172.44M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001493152-19-016855
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 482.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051418

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →